| Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials | |
| Wu, Lile; Zhang, Zhongqiang; Yao, Hongliang; Liu, Kuijie; Wen, Yu; Xiong, Li* | |
| 刊名 | Drug design, development and therapy
 |
| 2014 | |
| 卷号 | 8页码:2061-2067 |
| 关键词 | Randomized controlled trials evaluating the clinical efficacy of second-generation TKIs were identified by searching PubMed and EMBASE from 2000 to February 2014. Outcomes subjected to analysis were progression-free survival and overall survival. Statistical analyses were performed using Review Manager version 5.1.0 (Cochrane Collaboration Oxford UK). Weighted hazard ratios (HR) with 95% confidence intervals (CIs) were calculated for the outcomes. Fixed-effects or random-effects models were used depending on the degree of heterogeneity across the selected studies. |
| ISSN号 | 1177-8881 |
| DOI | 10.2147/DDDT.S63840 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000343995300001 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3334163 |
| 专题 | 中南大学 |
| 作者单位 | 1.[Liu, Kuijie 2.Xiong, Li 3.Wu, Lile 4.Zhang, Zhongqiang 5.Wen, Yu 6.Yao, Hongliang] Cent S Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha 410011, Hunan, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Wu, Lile,Zhang, Zhongqiang,Yao, Hongliang,et al. Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials[J]. Drug design, development and therapy,2014,8:2061-2067. |
| APA | Wu, Lile,Zhang, Zhongqiang,Yao, Hongliang,Liu, Kuijie,Wen, Yu,&Xiong, Li*.(2014).Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials.Drug design, development and therapy,8,2061-2067. |
| MLA | Wu, Lile,et al."Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials".Drug design, development and therapy 8(2014):2061-2067. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论